4.6 Article

A novel fungal metabolite inhibits Plasmodium falciparum transmission and infection

Journal

PARASITES & VECTORS
Volume 14, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13071-021-04677-7

Keywords

Fungal metabolites; Antimalarial agent; Malaria; Mosquito; FREP1-mediated Plasmodium transmission; Purpureocillium lilacinum

Funding

  1. NIH [R01AI125657]
  2. NSF [1453287, 1742644]
  3. China Scholarship Council [201808430054]
  4. Division Of Integrative Organismal Systems
  5. Direct For Biological Sciences [1742644] Funding Source: National Science Foundation
  6. Division Of Integrative Organismal Systems
  7. Direct For Biological Sciences [1453287] Funding Source: National Science Foundation

Ask authors/readers for more resources

The study revealed that an extract from the fungus Purpureocillium lilacinum contained a new compound named pulixin, which effectively blocked malaria transmission and inhibited parasite proliferation. Pulixin showed no cytotoxic effects and efficiently blocked parasite transmission to mosquitoes without harming the host cells.
Background: Malaria transmission depends on infected mosquitoes and can be controlled by transmission-blocking drugs. The recently discovered FREP1-mediated malaria transmission pathway is an excellent target to screen drugs for limiting transmission. Methods: To identify candidate small molecules, we used an ELISA-based approach to analyze extracts from a fungal library for inhibition of the FREP1-parasite interaction. We isolated and determined one active compound by chromatography and crystallography, respectively. We measured the effects of the bioactive compound on malaria transmission to mosquitoes through standard membrane-feeding assays (SMFA) and on parasite proliferation in blood by culturing. Results: We discovered the ethyl acetate extract of the fungus Purpureocillium lilacinum that inhibited Plasmodium falciparum transmission to mosquitoes. Pre-exposure to the extract rendered Anopheles gambiae resistant to Plasmodium infection. Furthermore, we isolated one novel active compound from the extract and identified it as 3-amino-7,9-dihydroxy-1-methyl-6H-benzo[c]chromen-6-one, or pulixin. Pulixin prevented FREP1 from binding to P. falciparum-infected cell lysate. Pulixin blocked the transmission of the parasite to mosquitoes with an EC50 (the concentration that gave half-maximal response) of 11 mu M based on SMFA. Notably, pulixin also inhibited the proliferation of asexual-stage P. falciparum with an EC50 of 47 nM. The compound did not show cytotoxic effects at a concentration of 116 mu M or lower. Conclusion: By targeting the FREP1-Plasmodium interaction, we discovered that Purpureocillium lilacinum extract blocked malaria transmission. We isolated and identified the bioactive agent pulixin as a new compound capable of stopping malaria transmission to mosquitoes and inhibiting parasite proliferation in blood culture.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available